Literature DB >> 21228551

Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332.

H Jedlickova, A Niedermeier, S Zgažarová, M Hertl.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21228551     DOI： 10.1159/000322842

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  6 in total

1.  Brunsting-Perry Type Pemphigoid Causing Secondary Cicatricial Alopecia in 2 Patients.

Authors:  Maria Fernanda Reis Gavazzoni Dias; Enöi Aparecida Guedes Vilar; Camila de Oliveira Bento; Raquel Barreto Ibanez; Aline Falci Loures; Maria Barreto Oliveira Campos; Júlia Monaco Santos
Journal:  Skin Appendage Disord       Date:  2018-04-20

2.  Localized Blistering Eruption of the Face and Neck - A Case Study and Differential Considerations.

Authors:  Małgorzata Michalska-Jakubus; Anita Wdowiak-Filip; Cezary Kowalewski; Katarzyna Woźniak; Dorota Krasowska
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-19

Review 3.  Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

Authors:  Angelo Ruggiero; Matteo Megna; Alessia Villani; Rosita Comune; Gabriella Fabbrocini; Francesca di Vico
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-14

4.  A large scalp ulceration.

Authors:  Karla Guerra; Andrew Fultz; Chad Johnston; David Rowe
Journal:  JAAD Case Rep       Date:  2021-06-11

5.  Brunsting-Perry pemphigoid transitioning from previous bullous pemphigoid.

Authors:  Shengru Zhou; Yaru Zou; Meng Pan
Journal:  JAAD Case Rep       Date:  2020-02-19

6.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.